International Clinical Trial: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study With A Food Effect Assessment To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Single Ascending Doses And Multiple Ascending Doses Of PX578 In Healthy Adult Participants (Part C)

Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ACTRN12625000452493) titled 'A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study With A Food Effect Assessment To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Single Ascending Doses And Multiple Ascending Doses Of PX578 In Healthy Adult Participants (Part C)' on May 14.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Crossover

Primary Sponsor: Pretzel Therapeutics Inc.

Condition: Mitochondrial disease Mitochondrial disease Human Genetics and Inherited Disorders - Other human genetics and inherited disorders Neurologi...